MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Debt to Asset Ratio
25.79%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses
    • Other receivable
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Common stock 0.001 par value, 25...
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
10,656,386
9,254,813
7,556,100
-
Other receivable
95,307
56,313
48,417
-
Prepaid expenses
233,084
228,826
85,018
-
Total assets
10,984,777
9,539,952
7,689,535
6,105,211
Accounts payable and accrued expenses
2,832,746
2,526,809
2,420,943
2,468,175
Total current liabilities
2,832,746
2,526,809
2,420,943
2,468,175
Total liabilities
2,832,746
2,526,809
2,420,943
2,468,175
Common stock 0.001 par value, 250,000,000 shares authorized, 4,683,253 and 2,348,113 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
4,683
3,389
2,348
1,800
Additional paid-in capital
87,370,997
83,979,230
80,554,738
77,345,454
Accumulated deficit
-79,223,649
-76,969,476
-75,288,494
-73,710,218
Total shareholders' equity
8,152,031
7,013,143
5,268,592
3,637,036
Total liabilities and shareholders' equity
10,984,777
9,539,952
7,689,535
6,105,211
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$10,656,386 Prepaid expenses$233,084 Other receivable$95,307 Total assets$10,984,777 Total liabilities andshareholders' equity$10,984,777 Total shareholders'equity$8,152,031 Total liabilities$2,832,746 Accumulated deficit-$79,223,649 Additional paid-in capital$87,370,997 Total currentliabilities$2,832,746 Common stock 0.001 parvalue, 250,000,000...$4,683 Accounts payable andaccrued expenses$2,832,746

Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals, Inc. (ACXP)